[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100524256":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":25,"locations":34,"responsibleParty":59,"collaborators":10,"id":61,"slug":62,"hasResults":63,"nctId":64,"briefTitle":65,"officialTitle":66,"acronym":10,"eligibilityCriteria":67,"healthyVolunteers":63,"sex":68,"minAge":69,"maxAge":10,"enrollmentInfo":70,"targetDuration":73,"studyType":74,"phases":10,"briefSummary":75,"conditions":76,"keywords":79,"overallStatus":36,"whyStopped":10,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":85,"completionDateStruct":87,"leadSponsor":89,"locationsCount":90},{"fullName":5,"class":6},"Inova Health Care Services","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"3 Cohorts",null,"Cohort 1: Daily from day 2 through the end of treatment cycle (n=34) Cohort 2: Daily days 2-9 then every third day through end of cycle (n=33) Cohort 3: Daily days 2-9 for all symptoms, every third day thereafter regarding 'pain' only through end of cycle (n=33)",[13],"Device: Locus Health iPhone App",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"DEVICE","Locus Health iPhone App","In this pilot study patients are enrolled into three (3) different groups which will vary by the frequency of the queries being sent to the patients during their chemotherapy cycle. The patients will be separated into three groups of 33-34 patients each. Each group will have a different frequency of symptom questions sent to them via the Locus Health iPhone App to determine patient fatigue and the compliance impact of different query cadences. Patients will be assigned to these 3 groups sequentially since the platform could not assign patients to these three cohorts in a random manner.",[9],[21],{"name":22,"affiliation":23,"role":24},"John Deeken, MD","Inova Schar Cancer Institute","PRINCIPAL_INVESTIGATOR",[26,31],{"name":27,"role":28,"phone":29,"phoneExt":10,"email":30},"Elahe Mollapour","CONTACT","(571) 472-4724","elahe.mollapour@inova.org",{"name":32,"role":28,"phone":10,"phoneExt":10,"email":33},"Keary Jane't","Keary.Janet@inova.org",[35],{"facility":23,"status":36,"city":37,"state":38,"zip":39,"country":40,"countryCode":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"RECRUITING","Fairfax","Virginia","22031","United States","US",{"type":43,"coordinates":44},"Point",[45,46],-77.30637,38.84622,{"lat":46,"lon":45},[49,51,53,54,57],{"name":27,"role":28,"phone":50,"phoneExt":10,"email":30},"571-472-4724",{"name":32,"role":28,"phone":10,"phoneExt":10,"email":52},"keary.janet@inova.org",{"name":22,"role":24,"phone":10,"phoneExt":10,"email":10},{"name":55,"role":56,"phone":10,"phoneExt":10,"email":10},"Jasmine Huynh, MD","SUB_INVESTIGATOR",{"name":58,"role":56,"phone":10,"phoneExt":10,"email":10},"Melisa Yacur, MD",{"type":60,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100524256","a-pilot-prospective-clinical-trial-using-remote-monitoring-for-cancer-patients-undergoing-outpatient-chemotherapy-100524256",false,"NCT06106360","A Pilot Prospective Clinical Trial Using Remote Monitoring for Cancer Patients Undergoing Outpatient Chemotherapy","A Pilot Prospective Clinical Trial Using Remote Patient Monitoring for Cancer Patients Undergoing Outpatient Chemotherapy","Inclusion Criteria:\n\n* Planned to be treated with a new cytotoxic chemotherapy or chemoimmunotherapy regimen for a solid tumor or malignant hematology condition for at least 4 months\n* ECOG performance status of 0-2\n* Age of 18 or older patient with any solid tumor or hematologic malignancy\n* English or Spanish speaker\n* Own an Apple iPhone\n* Capacity and willingness to provide informed consent\n\nExclusion Criteria:\n\n* Patients undergoing concurrent radiation since they will be seen on a daily basis by clinic care teams and are not likely to benefit from active remote patient monitoring\n* Patients unwilling or unable to comply with the protocol, including wearing the Apple Watch (including recharging daily) and answering queries on the Locus Health iPhone application per the protocol and study group cadence\n* Any condition for which in the Investigator's opinion would limit compliance with study requirements","ALL","18 Years",{"count":71,"type":72},100,"ESTIMATED","120 Days","OBSERVATIONAL","A pilot study using remote monitoring technology developed by Locus Health in cancer patients undergoing chemotherapy treatment.",[77,78],"Solid Tumor","Hematological Malignancy",[80],"Wearable Electronic Devices","2025-12-04",{"date":83,"type":84},"2025-12-08","ACTUAL",{"date":86,"type":84},"2023-10-26",{"date":88,"type":72},"2026-06-26",{"name":5,"class":6},1]